metoclopramide hydrochloride NDC 68999-526

NDC codes

FDA NDC Directory

Product NDC (as listed)68999-526Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68999-0526Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68999-526-24	68999052624	2 TRAY in 1 BOX (68999-526-24) / 10 CUP in 1 TRAY / 10 mL in 1 CUP (68999-526-10)Marketed from Oct 29, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): metoclopramide hydrochloride
Generic name (nonproprietary): metoclopramide hydrochloride
Active ingredients: Metoclopramide hydrochloride — 5 mg/5mL
Dosage form: Solution
Route: Oral
Labeler: Chartwell Governmental & Specialty RX, LLC.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 073680
Marketing start: Oct 27, 1992
Listing expires: Dec 31, 2026
Other FDA classes: Dopamine D2 Antagonists (Mechanism)
Identifiers: Product ID 68999-526_4367fc1e-eb19-0e80-e063-6394a90a58bdSPL ID 4367fc1e-eb19-0e80-e063-6394a90a58bdSPL set ID c4ab34f2-25e6-47bd-9dde-1f4baf469f0dRxCUI 104884UNII W1792A2RVD
Pharmacologic class: Dopamine-2 Receptor Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468999052624 followed by a unit qualifier and the quantity

Package 68999-0526-24. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 12, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE The use of Metoclopramide Oral Solution is recommended for adults only. Therapy should not exceed 12 weeks in duration. Symptomatic Gastroesophageal Reflux Metoclopramide Oral Solution is indicated as short-term (4 to 12 weeks) therapy for adults with symptomatic, documented gastroesophageal reflux who fail to respond to conventional therapy. The principal effect of metoclopramide is on symptoms of postprandial and daytime heartburn with less observed effect on nocturnal symptoms. If symptoms are confined to particular situations, such as following the evening meal, use of metoclopramide as single doses prior to the provocative situation should be considered, rather tha…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 073680

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 073680
Product	Strength	Form · route	Labeler	Product NDC
metoclopramide hydrochloride	Metoclopramide hydrochloride 5 mg/5mL	SolutionOral	Chartwell RX, LLC	62135-526